The electronic prescription for public choice mutualists is already interoperable in nine autonomous communities, a measure that benefits more than 115,000 members. It is expected that in 2021 this system will be extended to the remaining territories.
In October, the Ministry of Health and the various regional health departments began the process of incorporating this part of the mutualist collective into the benefits of the Interoperable Electronic Prescription throughout the National Health System. This work also highlights the coordination work carried out by MUFACE and the General Council of Official Pharmaceutical Colleges (CGCOF).
On 5 October the first six autonomous communities - Asturias, Aragon, Extremadura, La Rioja, Navarra and the Basque Country - came into service, and on 2 November three other communities - Andalusia, Cantabria and Murcia - also joined, benefiting 115,171 MUFACE mutualists benefiting from the public option of health care and who can already withdraw the prescriptions prescribed in any of these communities. The service is available at 2,166 health centres and 8,200 pharmacy offices in these territories.
Interoperability is expected to be progressively extended to the remaining autonomous communities already incorporated into their electronic prescription systems to the MUFACE mutualists, so that the process will end in the first quarter of 2021, when all mutualists assisted by the SNS will be able to go to any pharmacy office in the country to obtain the medicines dispensed by electronic prescription.
The Electronic Prescription Interoperability Service of the National Health System, which has been available in all AACC since April 2019, has been used to date by 2,241,385 million people, who have required 9,256,634 million dispensing acts in which 22,233,776 million drug packages have been withdrawn outside the prescribed community. Since its inception in 2015, its use has been on the increase being a service greatly appreciated by the population served by the public health system.